Valuation: CellSource Co., Ltd.

Market Cap 5.92B 37.39M 33.55M 31.01M 28.09M 52.48M 3.56B 53.11M 371M 148M 1.86B 140M 137M P/E 2026 *
-59.6x
P/E 2027 * 74.5x
Enterprise Value 5.92B 37.39M 33.55M 31.01M 28.09M 52.48M 3.56B 53.11M 371M 148M 1.86B 140M 137M EV / Sales 2026 *
1.76x
EV / Sales 2027 * 1.69x
Free-Float
45.74%
Yield 2026 *
-
Yield 2027 * -
1 day-3.56%
1 week-4.49%
Current month-5.70%
1 month-8.31%
3 months-7.17%
6 months-19.68%
Current year-25.31%
1 week 298
Extreme 298
320
1 month 298
Extreme 298
333
Current year 294
Extreme 294
442
1 year 294
Extreme 294
525
3 years 294
Extreme 294
1,924
5 years 294
Extreme 294
8,160
10 years 294
Extreme 294
8,160
Manager TitleAgeSince
Chief Executive Officer 62 01/11/2025
Director of Finance/CFO - 01/01/2026
Corporate Officer/Principal - 01/01/2024
Director TitleAgeSince
Director/Board Member 64 01/06/2017
Chairman 62 25/01/2024
Director/Board Member 57 01/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.56%-4.49%-42.91%-85.03% 38.85M
+0.50%+1.38%+57.09%+127.73% 1,143B
+0.86%+5.14%+45.00%+84.34% 647B
-0.14%+0.42%+25.69%+101.56% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-0.63%-5.97%+61.93%+37.25% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.87%+3.08%+54.69%+71.67% 242B
+0.08%+3.67%+35.05%+104.71% 197B
Average -0.08%+0.97%+32.29%+58.51% 402.76B
Weighted average by Cap. +0.53%+0.87%+44.50%+86.93%

Financials

2026 *2027 *
Net sales 3.37B 21.3M 19.11M 17.67M 16M 29.9M 2.03B 30.26M 211M 84.14M 1.06B 79.93M 78.24M 3.5B 22.12M 19.85M 18.35M 16.62M 31.05M 2.11B 31.42M 219M 87.39M 1.1B 83.01M 81.26M
Net income -100M -632K -567K -524K -475K -887K -60.2M -898K -6.27M -2.5M -31.5M -2.37M -2.32M 80M 506K 454K 419K 380K 710K 48.16M 718K 5.01M 2M 25.2M 1.9M 1.86M
Net Debt - -
Projected Income Statement - Annual - CellSource Co., Ltd.
Logo CellSource Co., Ltd.
CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.
Employees
148
Date Price Change Volume
28/10/26 ¥298.00 -3.56% 121,600
27/10/26 ¥309.00 +0.32% 78,700
26/10/26 ¥308.00 -1.60% 41,500
23/10/26 ¥313.00 -0.95% 37,000
22/10/26 ¥316.00 -0.32% 24,600
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - CellSource Co., Ltd.

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CellSource Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 4880 Stock